Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06847672
Starting soon Observational

Comparison of the Time to Reach End-Tidal Oxygen Value of 90 and Oxygen Reserve Index Decline Times During Preoxygenation in Sarcopenic and Non-Sarcopenic Patients

NCT06847672 · tracked via the Priya Life Science Turkey tracker
Sponsor
Ankara City Hospital Bilkent
Phase
Observational
Started
2025-03-01
Last updated
2025-02-26

Condition(s) studied

SarcopeniaPreoxygenationOxygen Reserve Index

Investigational drug(s) / intervention(s)

preoxygenation

preoxygenation: The time required to reach EtO2 90% and the time until ORI drops below 0.55

Study summary

The purpose of this study is to compare the time required to reach an end-tidal oxygen (EtO2) value of 90% and the time until the Oxygen Reserve Index (ORI) drops below 0.55 during preoxygenation in sarcopenic and non-sarcopenic patients. The study aims to investigate the impact of sarcopenia on the oxygenation process.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients who agree to participate in the study. * Patients scheduled for major abdominal oncologic surgery. Exclusion Criteria: * Patients with severe cardiopulmonary disease. * Patients with walking disabilities.

Primary outcome measure(s)

  • Time required to reach EtO2 90% — preoperatively
  • Time until ORI drops below 0.55 — preoperatively

Trial sites (1)

FacilityCityRegionStatus
Ankara City Hospital Bilkent Ankara Turkey (Türkiye)

More Ankara City Hospital Bilkent trials in Turkey

The Effectiveness of Transcutaneous Sacral Neuromodulation Techniques-Magnetic Stimulation and Electrical Stimulation-on Detrusor Overactivity in Patients With Spinal Cord Injury Recruiting
Mechanical Power Ventilation in RALP Starting soon
Conventional Versus High-Voltage Long-Duration Pulsed Radiofrequency of the Pudendal Nerve Recruiting
Phoenixin and Pain in Pediatric Burn Patients Starting soon
Anterior Cruciate Ligament Reconstruction With a Periosteal - Patellar Tendon - Bone Autograft - The Kocabey Press-Fit Technique Recruiting

Other trials for the same condition

Does Sarcopenia Influence Rotator Cuff Tear Patterns? Radiological Insights From Patients With Rotator Cuff Syndrome Recruiting
Effects of Aquatic Exercise in Older Adults With Sarcopenia:A Randomized Trial Active, not recruiting
Malnutrition Screening Study Recruiting
Examining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver Cirrhosis Starting soon
Sarcopenia and Related Factors in Patients With Multiple Sclerosis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06847672 on ClinicalTrials.gov ↗ ← All trials in Turkey